J. Maloteaux

[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.

Y. Agid, F. Javoy‐Agid, C. Laterre, 1988, European journal of pharmacology.

Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy

Y. Agid, F. Javoy‐Agid, J. Maloteaux, 1988, Movement disorders : official journal of the Movement Disorder Society.

Failure of a peripheral dopaminergic marker in Parkinson's disease.

C. Laterre, P. Laduron, L. Hens, 1983, Journal of neurology, neurosurgery, and psychiatry.

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

K. Jellinger, L. Iversen, K. Lesch, 1995, Journal of Neural Transmission / General Section JNT.

Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P

J. Maloteaux, A. Jeanjean, P. Laduron, 1995, Neuroscience.

Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex

Y. Agid, M. Ruberg, B. Scatton, 1989, Neuroscience.

Brain glucose utilization in band heterotopia: synaptic activity of "double cortex".

A. Bol, C. Grandin, A. D. De Volder, 1994, Pediatric neurology.

Use of a placebo in clinical trials

G. Emilien, A. Seghers, J. Maloteaux, 1998, European Psychiatry.

1,3‐Diacylaminopropan‐2‐ols and Corresponding 2‐Acyl Derivatives as Drug Carriers: Unexpected Pharmacological Properties

J. Poupaert, B. Gallez, D. Lambert, 1993, The Journal of pharmacy and pharmacology.